About Jeff Goater
Form D filings for NILO Therapeutics in 2024 list Jeff Goater as chief financial officer and director.
Jeff Goater first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeff Goater in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Goater works with at each company, as listed on that company's latest Form D.
NILO Therapeutics, Inc. · Form D, Aug 2, 2024
TK
Tim Kutzkey
Executive officer, director and promoter